The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo

被引:106
|
作者
Duncan, GS
Mittrucker, HW
Kagi, D
Matsuyama, T
Mak, TW
机构
[1] AMGEN INST, TORONTO, ON M5G 2M9, CANADA
[2] UNIV TORONTO, ONTARIO CANC INST, DEPT IMMUNOL, TORONTO, ON M4X 1K9, CANADA
[3] UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON M4X 1K9, CANADA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 184卷 / 05期
关键词
D O I
10.1084/jem.184.5.2043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The activation of natural killer (NK) cells, cytotoxic lymphocytes capable of major histocompatibility complex (MHC)-unrestricted killing and early antiviral defense, is temporally related to the increased interferon (IFN)-alpha/beta production that is seen in the viral infection of mice. Type I IFN (IFN-alpha/beta) are expressed in many cell types early after primary viral infection and have been shown to mediate resistance against a variety of viruses. In this study, the role of the transcriptional activator IFN regulatory factor-1 (IRF-1) in murine NK cell activity was assessed. IRF-1-deficient mice displayed a normal frequency of NK marker-positive cells, but exhibited greatly reduced NK cell-mediated cytotoxicity after both virus infection and stimulation with the IFN inducer polyinosinic:polycytidilic acid in vivo. In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12. IRF-1-deficient mice were unable to eliminate syngeneic MHC class I-negative tumor cells in vivo, and had a reduced ability to reject parental semi-allogeneic donor cells from the circulation. Thus, IRF-1 is essential for the induction of NK cell-mediated cytotoxicity and for the in vivo effector functions that are mediated by this activity.
引用
收藏
页码:2043 / 2048
页数:6
相关论文
共 50 条
  • [1] Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1
    Taniguchi, T
    Tanaka, N
    Taki, S
    EUROPEAN CYTOKINE NETWORK, 1998, 9 : 43 - 48
  • [2] Regulatory effect of interferon regulatory factor-1 on lymphatic enhancing factor 1
    Feng, Wenming
    Cui, Ge
    Tang, Chengwu
    Bao, Ying
    Qin, Lianjin
    Fei, Maoyun
    Tao, Yulong
    Sun, Xinrong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 10898 - 10905
  • [3] The transcription factor interferon regulatory factor-1 is an endogenous mediator of myocardial ischemia reperfusion injury
    Jiang, Wenlong
    Chen, Guoxiong
    Pu, Jun
    CELL BIOLOGY INTERNATIONAL, 2022, 46 (01) : 63 - 72
  • [4] Stimulation of interferon regulatory factor-1 by prolactin
    Yu-Lee, LY
    LUPUS, 2001, 10 (10) : 691 - 699
  • [5] Interferon regulatory factor-1 myelodysplasia and leukemia
    Liebermann, Dan A.
    Hoffman, Barbara
    LEUKEMIA RESEARCH, 2006, 30 (09) : 1069 - 1071
  • [6] Interaction of interferon regulatory factor-1 and nuclear factor kappa B during induction of iNOS transcription
    Saura, M
    Zaragoza, C
    McMillan, A
    Lowenstein, CJ
    CIRCULATION, 1997, 96 (08) : 3077 - 3077
  • [7] Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack
    C. Gysemans
    H. Callewaert
    F. Moore
    M. Nelson-Holte
    L. Overbergh
    D. L. Eizirik
    C. Mathieu
    Diabetologia, 2009, 52 : 2374 - 2384
  • [8] Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter
    Spink, J
    Evans, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) : 24417 - 24425
  • [9] Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack
    Gysemans, C.
    Callewaert, H.
    Moore, F.
    Nelson-Holte, M.
    Overbergh, L.
    Eizirik, D. L.
    Mathieu, C.
    DIABETOLOGIA, 2009, 52 (11) : 2374 - 2384
  • [10] Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-κB, and PU.1
    Liu, Jianguo
    Ma, Xiaojing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) : 19188 - 19195